← Addex Therapeutics Ltd.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue from contract with customer — $6.0m $2.8m $3.6m $2.9m $1.4m $1.6m $404k $30k
Revenue From Interest — — $37k $35k $5k $29k $64k $9k $0
Research and development ($2.6m) $4.9m $12.5m $10.4m $12.8m $14.7m $7.0m $854k ($672k)
Operating expenses:
Other Operating Expenses — — — — — $809k $870k $856k $758k
Total operating costs ($3.7m) ($8.1m) ($17.4m) ($16.1m) ($18.7m) ($22.0m) ($11.9m) ($3.2m) ($3.0m)
Additional Financial Items
General and administrative — $3.2m $5.0m $5.7m $5.8m $7.3m $5.0m $2.3m —
Applicable Tax Rate — $0 $0 $0 $0 $0 $0 — —
Depreciation Right of Use Assets — — $324k $359k $320k $292k $281k $74k —
Finance Income — — $37k $35k $217k $29k $64k $27k $0
Other Income $500k $659k $71k $266k $237k $23k $34k $6k $143k
Profit Loss Before Tax ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) ($4.9m) ($6.8m)
Profit Loss From Operating Activities ($3.2m) ($1.4m) ($14.6m) ($12.2m) ($15.5m) ($20.5m) ($10.3m) ($2.8m) ($2.8m)
General and administration ($1.1m) ($3.2m) ($5.0m) ($5.7m) ($5.8m) ($7.3m) ($5.0m) ($2.3m) ($2.3m)
Operating loss ($3.2m) ($1.4m) ($14.6m) ($12.2m) ($15.5m) ($20.5m) ($10.3m) ($2.8m) ($2.8m)
Interest Income — — $37k $35k $217k $29k $64k $27k $0
Finance result ($45k) ($220k) ($176k) ($615k) $154k ($284k) ($275k) $23k ($16k)
Share of net loss of investments accounted for using the equity method — — — — — — — ($2.2m) ($4.0m)
Net loss before tax from continuing operations ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) ($4.9m) ($6.8m)
Net loss from continuing operations — — — — — ($10.8m) ($2.5m) ($4.9m) ($6.8m)
Net profit / (loss) from discontinued operations (attributable to equity holders of the Group) — — — — — ($10.0m) ($8.1m) $12.0m $114k
Net profit / (loss) for the period ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
From continuing operations — — — — — ($0) ($0) ($0) ($0)
From discontinued operations — — — — — ($0) ($0) $0 —
Depreciation Amortization Depletion Income Statement — — — — — $9k $12k $193k $8k
Depreciation And Amortization In Income Statement — — — — — $9k $12k $193k $8k
Depreciation Income Statement — — — — — $9k $12k $193k $8k
Diluted EPS — — — — — ($55.20) ($16.80) $8.40 ($7.20)
Diluted NI Availto Com Stockholders ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
Earnings From Equity Interest — — — — — $0 $0 ($2.2m) ($4.0m)
Gain On Sale Of Security — — — — — ($264k) ($317k) $17k ($13k)
Insurance And Claims — — — — — $1.6m $629k $226k $184k
Interest Income Non Operating — — $37k $35k $5k $29k $64k $9k $0
Net Income From Continuing And Discontinued Operation ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
Net Income From Continuing Operation Net Minority Interest — — — — — ($10.8m) ($2.5m) ($4.9m) ($6.8m)
Net Interest Income — — — — — $1k $60k $6k ($2k)
Normalized EBITDA — — — — — ($10.2m) ($1.9m) ($4.7m) ($6.8m)
Normalized Income — — — — — ($10.5m) ($2.2m) ($4.9m) ($6.8m)
Other Gand A — — — — — $1.4m $1.2m $1.2m $1.3m
Reconciled Depreciation — — — — — $323k $306k $260k $8k
Rent And Landing Fees — — — — $38k $47k $36k — —
Salaries And Wages — — — — — $253k $239k $243k $389k
Selling General And Administration — — — — — $3.3m $2.0m $1.7m $1.9m
Tax Effect Of Unusual Items — $0 $0 $0 $0 $0 $0 $0 $0
Tax Provision — $0 $0 $0 $0 $0 $0 $0 $0
Tax Rate For Calcs — $0 $0 $0 $0 $0 $0 $0 $0
Net Foreign Exchange Loss — $86k $85k $581k — — — — —
Total Unusual Items — — — — — ($264k) ($317k) $17k ($13k)
Total Unusual Items Excluding Goodwill — — — — — ($264k) ($317k) $17k ($13k)
Pre-Tax Income — — — — — ($10.8m) ($2.5m) ($4.9m) ($6.8m)
Net Income ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
Net Income Continuous Operations — — — — — ($10.8m) ($2.5m) ($4.9m) ($6.8m)
Net Income Discontinuous Operations — — — — — ($10.0m) ($8.1m) $12.0m $114k
Net Income Including Noncontrolling Interests ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
Basic Earnings (Loss) Per Share ($0.25) ($0.07) ($0.56) ($0.48) ($0.45) ($0.46) ($0.14) $0.07 ($0.06)
Diluted Earnings (Loss) Per Share ($0.25) ($0.07) ($0.56) ($0.48) ($0.45) ($0.46) ($0.14) $0.07 ($0.06)
Basic Average Shares — — — — — $377k $619k $818k $895k
Diluted Average Shares — — — — — $685k $619k $818k $895k
Employee Benefits Expense — $2.2m $4.3m $4.4m $4.7m $7.1m $5.4m $243k —
Expense From Share-Based Payment Transactions With Employees — $719k $1.3m $901k $947k $3.0m $1.5m $18k —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — — $26k $37k $38k $47k $36k — —
Finance Costs — $220k $213k $651k $63k $313k $339k $4k —
Postemployment Benefit Expense Defined Benefit Plans — $119k $296k $221k $114k $280k $236k ($45k) —
Professional Fees Expense — $2.3m $2.0m $1.4m $1.4m $1.4m $1.2m $1.2m —
Finance expense ($45k) ($220k) ($213k) ($651k) ($63k) ($313k) ($339k) ($4k) ($16k)
Interest Expense — $134k $106k $50k $39k $26k $2k $2k $2k
Interest Expense On Lease Liabilities — — $23k $19k $24k $23k $20k $2k —
Income Tax Expense Continuing Operations — $0 $0 $0 $0 $0 $0 $0 $0
Income tax expense — $0 $0 $0 $0 $0 $0 $0 $0
General And Administrative Expense — — — — — $3.3m $2.0m $1.7m $1.9m
Interest Expense Non Operating — — — — — $28k $4k $4k $2k
Net Non Operating Interest Income Expense — — — — — $1k $60k $6k ($2k)
Operating Expense — — — — — $12.0m $3.9m $3.2m $2.8m
Other Income Expense — — — — — ($264k) ($317k) ($2.2m) ($4.0m)
Rent Expense Supplemental — — — — $38k $47k $36k — —
Total Expenses — — — — — $12.0m $3.9m $3.2m $2.8m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.